Amedeo Smart

Free Medical Literature Service



Multiple Sclerosis

  Free Subscription

Articles published in
Eur Neurol
    May 2021
  1. SZILASIOVA J, Rosenberger J, Fedicova M, Mikula P, et al
    Neurofilament Light Chain Levels Are Associated with Disease Activity Determined by No Evident Disease Activity in Multiple Sclerosis Patients.
    Eur Neurol. 2021 May 25:1-8. doi: 10.1159/000515806.
    >> Share

    April 2021
  2. ARICI DUZ O, Saatci O, Karakulak EZ, Birday E, et al
    Olfactory Dysfunction and Cognition in Radiologically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis.
    Eur Neurol. 2021 Apr 8:1-8. doi: 10.1159/000514433.
    >> Share

  3. UZUNKOPRU C, Beckmann Y, Ture S
    Long-Term Effectiveness of Fingolimod for Multiple Sclerosis in a Real-World Clinical Setting.
    Eur Neurol. 2021 Apr 7:1-6. doi: 10.1159/000514828.
    >> Share

    March 2021
  4. ALHOMOUD MA, Khan AS, Alhomoud I
    The Potential Preventive Effect of Pregnancy and Breastfeeding on Multiple Sclerosis.
    Eur Neurol. 2021 Mar 19:1-14. doi: 10.1159/000514432.
    >> Share

    October 2020
  5. KAPICA-TOPCZEWSKA K, Collin F, Tarasiuk J, Czarnowska A, et al
    John Cunningham Virus Status, Seroconversion Rate, and the Risk of Progressive Multifocal Leukoencephalopathy in Polish John Cunningham Virus-Seronegative Patients with Relapsing-Remitting Multiple Sclerosis.
    Eur Neurol. 2020 Oct 7:1-6. doi: 10.1159/000510849.
    >> Share

    September 2020
  6. CILINGIR V, Batur M
    Axonal Degeneration Independent of Inflammatory Activity: Is It More Intense in the Early Stages of Relapsing-Remitting Multiple Sclerosis Disease?
    Eur Neurol. 2020 Sep 21:1-9. doi: 10.1159/000510116.
    >> Share

    August 2020
    Progressive Multiple Sclerosis Transcriptome Deconvolution Indicates Increased M2 Macrophages in Inactive Lesions.
    Eur Neurol. 2020 Aug 28:1-3. doi: 10.1159/000510075.
    >> Share

    July 2020
  8. BUZGOVA R, Kozakova R, Skutova M
    Factors Influencing Health-Related Quality of Life of Patients with Multiple Sclerosis and Their Caregivers.
    Eur Neurol. 2020 Jul 28:331-339. doi: 10.1159/000508949.
    >> Share

  9. KOSEOGLU M, Tutuncu M
    Conversion of Optic Neuritis to Relapsing Remitting Multiple Sclerosis: A Retrospective Comorbidity Cohort Study.
    Eur Neurol. 2020 Jul 20:1-6. doi: 10.1159/000507547.
    >> Share

  10. MAGNIN E, Sagawa Y, Moulin T, Decavel P, et al
    What Are the Minimal Detectable Changes in SDMT and Verbal Fluency Tests for Assessing Changes in Cognitive Performance in Persons with Multiple Sclerosis and Non-Multiple Sclerosis Controls?
    Eur Neurol. 2020 Jul 7:1-8. doi: 10.1159/000508607.
    >> Share

    March 2020
  11. MECA-LALLANA J, Ayuso T, Martinez-Yelamos S, Duran C, et al
    Effectiveness of Fingolimod versus Natalizumab as Second-Line Therapy for Relapsing-Remitting Multiple Sclerosis in Spain: Second-Line GATE Study.
    Eur Neurol. 2020 Mar 18:1-9. doi: 10.1159/000505778.
    >> Share

    January 2020
  12. DEL BRUTTO OH, Mera RM, Costa AF, Silva P, et al
    Dawson Fingers in Older Adults with Cerebral Small Vessel Disease: A Population Study.
    Eur Neurol. 2020;83:421-425.
    >> Share

  13. MCKENNA MC, Al-Hinai M, Bradley D, Doran E, et al
    Patients' Experiences of Remote Neurology Consultations during the COVID-19 Pandemic.
    Eur Neurol. 2020;83:622-625.
    >> Share

    January 2019
  14. CZARNOWSKA A, Kapica-Topczewska K, Zajkowska O, Swierzbinska R, et al
    Herpesviridae Seropositivity in Patients with Multiple Sclerosis: First Polish Study.
    Eur Neurol. 2019;80.
    >> Share

  15. LADEIRA F, Salavisa M, Caetano A, Barbosa R, et al
    The Influence of Menopause in Multiple Sclerosis Course: A Longitudinal Cohort Study.
    Eur Neurol. 2019;80.
    >> Share

  16. RUBERTE E, Sinnecker T, Amann M, Gaetano L, et al
    Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis.
    Eur Neurol. 2019;80.
    >> Share

    October 2018
  17. GEBHARDT M, Kropp P, Hoffmann F, Zettl UK, et al
    Headache at the Time of First Symptom Manifestation of Multiple Sclerosis: A Prospective, Longitudinal Study.
    Eur Neurol. 2018;80.
    >> Share

  18. AVILA M, Bansal A, Culberson J, Peiris AN, et al
    The Role of Sex Hormones in Multiple Sclerosis.
    Eur Neurol. 2018;80.
    >> Share

    August 2018
  19. HOSL KM, Deutsch M, Wang R, Roy S, et al
    Sexual Dysfunction Seems to Trigger Depression in Female Multiple Sclerosis Patients.
    Eur Neurol. 2018;80.
    >> Share

    October 2017
  20. LECAT M, Decavel P, Magnin E, Lucas B, et al
    Multiple Sclerosis and Clinical Gait Analysis before and after Fampridine: A Systematic Review.
    Eur Neurol. 2017;78.
    >> Share

    July 2017
  21. GRASSO MG, Broccoli M, Casillo P, Catani S, et al
    Evaluation of the Impact of Cognitive Training on Quality of Life in Patients with Multiple Sclerosis.
    Eur Neurol. 2017;78.
    >> Share

  22. GONZALES B, Chopard G, Charry B, Berger E, et al
    Effects of a Training Program Involving Body Cooling on Physical and Cognitive Capacities and Quality of Life in Multiple Sclerosis Patients: A Pilot Study.
    Eur Neurol. 2017;78.
    >> Share

    May 2017
  23. KAUV P, Ayache SS, Creange A, Chalah MA, et al
    Adenosine Triphosphate Metabolism Measured by Phosphorus Magnetic Resonance Spectroscopy: A Potential Biomarker for Multiple Sclerosis Severity.
    Eur Neurol. 2017;77.
    >> Share

    April 2017
  24. HABEK M, Krbot Skoric M, Crnosija L, Gabelic T, et al
    Postural Orthostatic Tachycardia Predicts Early Conversion to Multiple Sclerosis after Clinically Isolated Syndrome.
    Eur Neurol. 2017;77.
    >> Share

    March 2017
  25. SAHRAIAN MA, Rezaali S, Hosseiny M, Doosti R, et al
    Sleep Disorder as a Triggering Factor for Relapse in Multiple Sclerosis.
    Eur Neurol. 2017;77.
    >> Share

  26. BURGGRAAFF J, Knol DL, Uitdehaag BM
    Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?
    Eur Neurol. 2017;77.
    >> Share

    January 2017
  27. VILLAVERDE-GONZALEZ R, Gracia Gil J, Perez Sempere A, Millan Pascual J, et al
    Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.
    Eur Neurol. 2017;77.
    >> Share

    December 2016
  28. MOREAU T, Bungener C, Heinzlef O, Suchet L, et al
    Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study.
    Eur Neurol. 2016;77.
    >> Share

    October 2016
  29. VERMERSCH P, Trojano M
    Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
    Eur Neurol. 2016;76.
    >> Share

  30. VILLAR-QUILES RN, Matias-Guiu JA, Ortega G, Gonzalez-Suarez I, et al
    Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population.
    Eur Neurol. 2016;76.
    >> Share

    January 2016
  31. PATTI F
    Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
    Eur Neurol. 2016;75 Suppl 1:9-12.
    >> Share

    THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
    Eur Neurol. 2016;75 Suppl 1:4-8.
    >> Share

    THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
    Eur Neurol. 2016;75 Suppl 1:1-3.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016